Updated results of the ASPEN trial from a cohort of patients with wild-type MYD88 waldenstrom macroglobulinemia (MYD88WT WM)
C. Buske,M. Dimopoulos,Garcia R. Sanz, H. -P Lee,M. Trneny,M. Varettoni,S. Opat,S. D'Sa,R. G. Owen,G. Cull,S. Mulligan,J. Czyz,J. Castillo,M. Motta,T. Siddiqi,Gironella M. Mesa,Granell M. Gorrochategui,D. Talaulikar, P. L. Zinzani,E. Askari, S. Grosicki,A. Oriol,J. Kloczko,A. Tedeschi,V Leblond,W. Y. Chan,J. Schneider,A. Cohen,J. Huang,C. S. Tam ONCOLOGY RESEARCH AND TREATMENT（2021）
AI 理解论文
溯源树
样例
